Home » News » Awards & Advancement » Redwood Bioscience names executive chairman

Redwood Bioscience names executive chairman

Tuesday, October 4, 2011

Redwood Bioscience has named Peter Van Vlasselaer, PhD, executive chairman to Redwood’s board of directors.  In this role, Vlasselaer will be actively guiding Redwood on drug and platform development as well as corporate strategy.  

Currently, Vlasselaer is the executive chairman of iPierian, where he was the interim CEO earlier this year.  He previously served as the founding CEO of Arresto Biosciences which was acquired by Gilead Sciences in December 2010.  

“We are very pleased to be able to access Peter’s proven abilities in shepherding novel technologies from research into the clinic and driving value for investors,” stated David Rabuka, co-founder, president & chief scientific officer.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!